SEC Form 4 · accession 0001179110-18-011611

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Brian J Blaser

Officer — Executive Vice President

Period of report

Sep 20, 2018

Accepted (ET)

Sep 21, 2018 · 5:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Sep 20, 2018	M	48,100	$27.0336	A	184,918	D
Common shares without par value	Sep 20, 2018	M	10,100	$29.292	A	195,018	D
Common shares without par value	Sep 20, 2018	S	900	$68.73	D	194,118	D
Common shares without par value	Sep 20, 2018	S	350	$68.735	D	193,768	D
Common shares without par value	Sep 20, 2018	S	100	$68.7375	D	193,668	D
Common shares without par value	Sep 20, 2018	S	1,800	$68.74	D	191,868	D
Common shares without par value	Sep 20, 2018	S	1,250	$68.745	D	190,618	D
Common shares without par value	Sep 20, 2018	S	800	$68.75	D	189,818	D
Common shares without par value	Sep 20, 2018	S	2,043	$68.755	D	187,775	D
Common shares without par value	Sep 20, 2018	S	1,757	$68.76	D	186,018	D
Common shares without par value	Sep 20, 2018	S	1,837	$68.765	D	184,181	D
Common shares without par value	Sep 20, 2018	S	3,020	$68.77	D	181,161	D
Common shares without par value	Sep 20, 2018	S	3,822	$68.775	D	177,339	D
Common shares without par value	Sep 20, 2018	S	2,400	$68.78	D	174,939	D
Common shares without par value	Sep 20, 2018	S	2,300	$68.785	D	172,639	D
Common shares without par value	Sep 20, 2018	S	7,807	$68.79	D	164,832	D
Common shares without par value	Sep 20, 2018	S	1,100	$68.795	D	163,732	D
Common shares without par value	Sep 20, 2018	S	1,500	$68.80	D	162,232	D
Common shares without par value	Sep 20, 2018	S	1,442	$68.805	D	160,790	D
Common shares without par value	Sep 20, 2018	S	4,522	$68.81	D	156,268	D
Common shares without par value	Sep 20, 2018	S	1,136	$68.815	D	155,132	D
Common shares without par value	Sep 20, 2018	S	5,800	$68.82	D	149,332	D
Common shares without par value	Sep 20, 2018	S	2,000	$68.825	D	147,332	D
Common shares without par value	Sep 20, 2018	S	6,240	$68.83	D	141,092	D
Common shares without par value	Sep 20, 2018	S	960	$68.835	D	140,132	D
Common shares without par value	Sep 20, 2018	S	3,214	$68.84	D	136,918	D
Common shares without par value	Sep 20, 2018	S	100	$68.845	D	136,818	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$27.0336	Sep 20, 2018	M	48,100	D	Feb 17, 2015	Feb 16, 2022	Common shares	48,100	0	D
Option (right to buy)^F1	$29.292	Sep 20, 2018	M	10,100	D	Jun 1, 2015	May 31, 2022	Common shares	10,100	0	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).